Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Self-injecting is not for everyone, and that is completely okay
A dose used in a study is not automatically a dose for routine care
Legitimate Research Directions: Some peptides DO have potential and are being properly studied: Thymosin Alpha-1: Immune support (approved in 35+ countries, trials in US) BPC-157: IF proper human trials ever happen LL-37: Antimicrobial applications Others: Many peptides have theoretical promise But ONLY if studied properly: Randomized controlled trials Safety studies FDA approval process Medical supervision The Problem: Most "wellness peptides" will NEVER go through this process because: They can't be patented (no profit incentive) Companies would rather sell in gray market Proper trials cost $100M+ If trials show they DON'T work, the market disappears So we're stuck in limbo: promising animal data, zero human data, aggressive marketing
Alex encourages anyone with documented experience or interest in DSIP to submit public comments to the hearing docket
US$ 27.51
US$ 25.75
US$ 26.85
US$ 22.91
US$ 26.96
US$ 27.25
US$ 29.14
US$ 23.85
